CLINICAL ASSESSMENT OF NUTRITIONAL AND METABOLIC STATUS IN HIV OUTPATIENTS Article Emerole K., Kozhevnikova G., Isakov V., Voznesenskiy S., Konnov V., Pilipenko V., Golub V., Polovinkina N., Barysheva I., Kharlamova T., Konnov D. Open AIDS Journal. Bentham Science Publishers. Vol. 14. 2020. P. 11-15
PHARMACOKINETICS OF THE NEW HEPATITIS C VIRUS NS3 PROTEASE INHIBITOR NARLAPREVIR FOLLOWING SINGLE-DOSE USE WITH OR WITHOUT RITONAVIR IN PATIENTS WITH LIVER CIRRHOSIS Article Isakov V., Koloda D., Tikhonova N., Krasavina E., Samsonov M., Kikalishvili T., Lekishvili K., Malaya I., Ryska M., Tolkacheva V. Antimicrobial Agents and Chemotherapy. Vol. 60. 2016.
BOCEPREVIR PLUS PEGINTERFERON/RIBAVIRIN FOR TREATMENT OF CHRONIC HEPATITUS C IN RUSSIA Article Isakov V., Nikitin I., Chulanov V., Ogurtsov P., Lukyanova E., Long J., Wahl J., Frans A World Journal of Hepatology. Baishideng Publishing Group Co. Vol. Vol8. 2016. P. 331-339
NON ALCOHOLIC (NASH) ANS ALCOHOLIC STEATOHEPATITIS (ASH) ARE ASSOCIATED WITH DIFFERENT PRODUCTION RATE OF EICOSANOID METABOLITES BY LIPOXYGENASE Article Selezneva K., Goryainov S., Volkovich S., Isakov V., Eller K. International Liver Congress 2014 (EASL). London, England, April 09 - 13, 2014. [б.и.]. 2014. P. 378-378